Neurotoxicity of Pyrethroids in neurodegenerative diseases: From animals' models to humans' studies

被引:2
|
作者
Arsuffi-Marcon, Rafael [1 ]
Souza, Lizandra Gomes [1 ]
Santos-Miranda, Artur [2 ]
Joviano-Santos, Julliane V. [3 ,4 ,5 ]
机构
[1] Fed Univ ABC UFABC, Ctr Math Comp & Cognit CMCC, Sao Bernardo Do Campo, SP, Brazil
[2] Univ Fed Minas Gerais, Dept Physiol & Biophys, Belo Horizonte, MG, Brazil
[3] Fac Ciencias Med Minas Gerais, Postgrad Program Hlth Sci, Belo Horizonte, MG, Brazil
[4] Lab Investigacoes NeuroCardiacas, Ciencias Med Minas Gerais LINC CMMG, Belo Horizonte, MG, Brazil
[5] Alameda Ezequiel Dias 275, BR-30130110 Belo Horizonte, MG, Brazil
基金
巴西圣保罗研究基金会;
关键词
Pyrethroids; Alzheimer's disease; Huntington's disease; Parkinson's disease; Amyotrophic lateral sclerosis; Autism; STRIATAL DOPAMINERGIC PATHWAYS; EARLY-LIFE EXPOSURE; PARKINSONS-DISEASE; OXIDATIVE STRESS; INSECTICIDE EXPOSURE; HUNTINGTONS-DISEASE; TYROSINE-HYDROXYLASE; SPECTRUM DISORDERS; LIPID-PEROXIDATION; PESTICIDE EXPOSURE;
D O I
10.1016/j.cbi.2024.110911
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Neurodegenerative diseases are associated with diverse symptoms, both motor and mental. Genetic and environmental factors can trigger neurodegenerative diseases. Chemicals as pesticides are constantly used in agriculture and also domestically. In this regard, pyrethroids (PY), are a class of insecticides in which its main mechanism of action is through disruption of voltage-dependent sodium channels function in insects. However, in mammals, they can also induce oxidative stress and enzyme dysfunction. This review investigates the association between PY and neurodegenerative diseases as Alzheimer's, Huntington's, Parkinson's, Amyotrophic Lateral Sclerosis, and Autism in animal models and humans. Published works using specific and non-specific models for these diseases were selected. We showed a tendency toward the development and/or aggravating of these neurodegenerative diseases following exposure to PYs. In animal models, the biochemical mechanisms of the diseases and their interaction with the insecticides are more deeply investigated. Nonetheless, only a few studies considered the specific model for each type of disease to analyze the impacts of the exposure. The choice of a specific model during the research is an important step and our review highlights the knowledge gaps of PYs effects using these models reinforcing the importance of them during the design of the experiments.
引用
收藏
页数:12
相关论文
共 50 条
  • [31] Transgenic models of neurodegenerative diseases
    Lee, MK
    Borchelt, DR
    Wong, PC
    Sisodia, SS
    Price, DL
    CURRENT OPINION IN NEUROBIOLOGY, 1996, 6 (05) : 651 - 660
  • [32] Yeast models of neurodegenerative diseases
    Tuite, Mick F.
    MOLECULAR BIOLOGY OF NEURODEGENERATIVE DISEASES: VISIONS FOR THE FUTURE, PT A, 2019, 168 : 351 - 379
  • [33] Animal models of neurodegenerative diseases
    Langui, Dominique
    Lachapelle, Francois
    Duyckaerts, Charles
    M S-MEDECINE SCIENCES, 2007, 23 (02): : 180 - 186
  • [34] In vitro Models of Neurodegenerative Diseases
    Slanzi, Anna
    Iannoto, Giulia
    Rossi, Barbara
    Zenaro, Elena
    Constantin, Gabriela
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [35] Animal models of neurodegenerative diseases
    Dawson, Ted M.
    Golde, Todd E.
    lagier-Tourenne, Clotilde
    NATURE NEUROSCIENCE, 2018, 21 (10) : 1370 - 1379
  • [36] METHYLMERCURY DEVELOPMENTAL NEUROTOXICITY - A COMPARISON OF EFFECTS IN HUMANS AND ANIMALS
    BURBACHER, TM
    RODIER, PM
    WEISS, B
    NEUROTOXICOLOGY AND TERATOLOGY, 1990, 12 (03) : 191 - 202
  • [37] Modulation of brain lipids by diet: Studies in animal models of neurodegenerative diseases
    Calon, Frederic
    CAHIERS DE NUTRITION ET DE DIETETIQUE, 2014, 49 (03): : 120 - 125
  • [38] Modeling infectious diseases in humans and animals
    Woolhouse, Mark
    NATURE, 2008, 453 (7191) : 34 - 34
  • [39] Atypical Prion Diseases in Humans and Animals
    Tranulis, Michael A.
    Benestad, Slvie L.
    Baron, Thierry
    Kretzschmar, Hans
    PRION PROTEINS, 2011, 305 : 23 - 50
  • [40] Preclinical Studies of Neurodegenerative Diseases
    Deglon, N.
    HUMAN GENE THERAPY, 2010, 21 (06) : 764 - 764